1000 items found for your search. If no results were found please broaden your search.
(7 hours ago)
Innovation in biomedical engineering is accelerating nationally and at Hopkins, a team of ambitious students is similarly pursuing new engineering challenges in the realm of fetal surgery. Led by current Center of Bioengineering Innovation and Design Master’s student Selena Shirkin, the team’s FetalCare Port System aims to address complications in fetal therapy procedures by providing a safer alternative to existing techniques.
(11/18/24 4:02am)
With Thanksgiving just around the corner, this week’s review highlights scientific breakthroughs we can all be grateful for — advancements that have made a profound impact on human health in the past month.
(11/18/24 5:00am)
Surface-enhanced Raman spectroscopy (SERS) may revolutionize heart attack diagnosis. The SERS technique is a valuable tool for the detection of trace amounts of contaminants in food and water or the identification of biological samples. Its applications range from cancer diagnosis to the detection of substances for homeland security and forensic investigations. Regarding its most recent clinical applications, SERS has been adapted to diagnose heart attacks in research settings at impressive speeds and accuracy levels.
(11/18/24 5:00am)
Andrew H. Song, a postdoctoral research fellow at Harvard Medical School, presented his work on applying deep learning tools to cancer pathology at a talk titled “Taming Large-Scale Pathology Data for Clinical Outcome Prediction” on Nov. 13. In his talk, Song delved into his efforts to leverage AI in improving cancer diagnostics, explaining how machine learning models can fundamentally alter the landscape of clinical outcome prediction.
(7 hours ago)
For some students, research is merely ticking another box for med school or a resume builder, but not for sophomore Brianna Gauto-Kennedy, a Chemical and Biomolecular Engineering (ChemBE) major, who is currently engaged in research in the Department of Materials Sciences and Engineering . In an interview with The News-Letter, she outlined her journey to her lab and described her current project.
(11/17/24 5:53pm)
Fei Miao, Pratt & Whitney Associate Professor at the University of Connecticut's School of Computing, delivered a talk titled “Learning and Control for Safety, Efficiency, and Resiliency of Embodied AI” on Nov. 8. Her presentation explored her team’s recent efforts to advance Multi-agent Reinforcement Learning (MARL) for Connected and Automated Vehicles (CAVs), which models multiple autonomous vehicles that can send and receive real-time information from nearby vehicles and infrastructure to enhance driving decisions.
(11/14/24 5:00am)
Eledon Pharmaceuticals, Inc. (Eledon), is a biotechnology company led by Dr. David-Alexandre C. Gros, its CEO and a 1999 graduate of the Johns Hopkins School of Medicine. Eledon recently announced that two out of the three subjects with Type 1 diabetes treated with Eledon’s drug, tegoprubart, were able to achieve insulin independence after islet cell transplantation between three and six months post-transplant, with the third on the trajectory for insulin independence.
(11/15/24 3:53am)
On Tuesday, Nov. 5, as part of the Johns Hopkins Medicine’s Department of Neurology and Neurosurgery Neuroimmunology Seminar Series, Dr. Amber Salter delivered an overview of her ongoing work concerning comorbidities in multiple sclerosis (MS) disease, titled “Examining Associations of Comorbidities in MS Disease-Modifying Therapy Clinical Trial.” Salter is an associate professor of Biostatistics at UT Southwestern Medical Center.
(11/12/24 5:00am)
Anna Gilmore is a professor of Public Health, Director of the Tobacco Control Research Group and Co-Director of the Center for 21st Century Public Health at the University of Bath in England. In an interview with The News-Letter, she discussed her work defining the influence of commercial entities on public health — known as commercial determinants of health (CDOH) — and further described the topics of her talk hosted by the Institute for Global Tobacco Control through the Bloomberg School of Public Health on Nov. 6, 2024.
(11/05/24 3:10pm)
As the leaves continue to change color, scientific research similarly advances with new progress and innovation. Here are some of the recent studies in the fields of biotechnology, health and chemistry.
(10/30/24 4:00am)
The Department of Biology hosted Detlef Weigel, director at the Max Planck Institute for Biology Tübingen and member of the National Academy of Sciences, on Friday, Oct. 25. Weigel gave a talk titled "Imperfect plants in an imperfect world,” which explored his research group’s work on genetic variation in the model organism Arabidopsis thaliana.
(10/30/24 4:00am)
Becky Zheng, a sophomore majoring in Neuroscience and Chemistry and minoring in Writing Seminars, started doing research in high school and now continues at the School of Medicine. She is currently working in a lab under Dr. Lee J. Martin, who studies the onset of neurodegenerative diseases like Alzheimer’s and amyotrophic lateral sclerosis. In an interview with The News-Letter, Zheng unraveled her research journey and shared how her time at the lab has seeped into her daily life.
(10/30/24 7:00am)
Neha Tripathi, a senior studying Molecular and Cellular Biology and Public Health, is currently a member of the Matunis Lab. The lab, located at the School of Medicine, generally focuses on stem cell dynamics and regeneration. During an interview with The News-letter, Tripathi shared information about her research journey and described not only her role but also the greater importance of her research work.
(10/31/24 7:00am)
In a buzzing corner of campus, a group of students is pushing the limits of student-led space innovation. The newly established student organization, JHU CubeSat Club (HopSat), is gearing up to launch a nanosatellite powered by passive solar propulsion, with the ambitious goal of deploying the largest solar sail ever sent into space.
(10/31/24 6:00am)
A chimera is an organism composed of cells from two or more distinct genotypes. Human-animal chimeras are a budding area of research and involve the introduction and growth of human tissues in an animal. Chimerism research holds great promise in improving the availability of organs for organ transplantation, which is a major issue due to the current severe organ shortage. Initial chimerism studies involved smaller organisms, such as one where researchers attempted to grow a rat pancreas in a mouse.
(10/29/24 10:42pm)
Let’s dive into the latest in scientific news and explore recent breakthroughs, discoveries and advancements that are shaping our understanding of the world. This week’s column looks into an unanticipated effect of a type 2 diabetes treatment, explores a recent report in the field of public health and dives into updates in ecology.
(10/25/24 8:11pm)
The Department of Computer Science hosted Tommi Jaakkola, a professor in the Department of Electrical Engineering and Computer Science at the Massachusetts Institute of Technology and the Institute for Data, Systems and Society, on Tuesday, Oct. 15. In his talk, titled “Generative AI for (Molecular) Sciences,” Jaakkola highlighted the advancements in generative artificial intelligence (AI) for molecular science and material design.
(10/23/24 10:30pm)
We hope that the fall break was a good time to take a rest. Before diving back into the semester, catch up on the newest scientific discoveries!
(10/14/24 4:00am)
As fall break looms ahead, let’s take a look at the recent scientific news. In the past week, laureates of the 2024 Nobel Prizes in Chemistry, Physics and Physiology or Medicine have been announced.
(10/09/24 7:00am)
The Johns Hopkins Institute for Clinical & Translational Research hosted the 14th annual Henrietta Lacks Memorial Lecture on Oct. 5 to honor the lasting legacy of Henrietta Lacks. Her cells, taken without her consent in 1951 became one of the most important tools in biomedical research, leading to countless breakthroughs in science. However, her story also brings to light the intersection of medical ethics, race and the treatment of marginalized communities in research.
